pharmaphorum

FEBRUARY 13, 2024

The alliance is with Roche Tissue Diagnostics (RTD), a unit of the Swiss pharma group that is concerned with the development of tissue-based tools to improve the diagnosis of cancer and grew out of Roche’s acquisition of Venta Medical Systems in 2008.

Pharma 67

Pharma Medical Patients 67

Medgadget

AUGUST 4, 2023

Researchers at Duke University have developed a gravity-powered microfluidic device that is intended for use as a diagnostic technology in low-resource areas. The researchers hope that the technology could unlock point-of-care diagnostics for those living in the most remote and low-resource areas.

Specialization 76

Specialization Electronics Medicine 76

pharmaphorum

FEBRUARY 14, 2024

UK patients very concerned about access to diagnostics Phil.Taylor Wed, 14/02/2024 - 10:41 Bookmark this

Patients 67

Patients 67

MedCity News

MARCH 20, 2023

The Covid-19 pandemic has transformed the way we think of diagnostics in our daily lives. In a recent webinar, BD Vice President for Diagnostics Nikos Pavlidis spoke with a clinician and an epidemiologist where they shared their perspectives on how testing developments have changed the way we track respiratory illnesses.

Physicians 87

Physicians 87

Pharmaceutical Technology

APRIL 1, 2024

Discover the innovative patent by Jubilant Pharmova Ltd for a stable radiopharmaceutical composition of tetrofosmin, ensuring high purity and effectiveness in diagnostic imaging.

52

52

pharmaphorum

OCTOBER 4, 2022

The FDA has approved Swiss pharmaceutical company Roche’s first companion diagnostic for identifying those patients with HER2 low-metastatic breast cancer who are eligible for ENHERTU. The post Roche gets FDA approval for HER2 breast cancer diagnostic appeared first on. HER2 is a receptor protein that accelerates cancer cell growth.

FDA 99

FDA Engineering Patients Pharmaceutical 99

PM360

JUNE 16, 2023

The healthcare industry has been transformed by the COVID-19 pandemic, and the diagnostic market is no exception. This has led to significant changes in the healthcare diagnostics market and has created new opportunities and challenges for pharma executives. The COVID-19 pandemic, however, changed all of that.

Marketing 52

Marketing Healthcare Healthcare Medical 52

MedCity News

JANUARY 12, 2023

Microsoft is making a strategic investment in Paige, which is leveraging AI for cancer diagnostics and treatment. Paige will also use Microsoft Azure as its cloud provider for the Paige Platform.

98

98

MedCity News

AUGUST 1, 2022

Andrew Dahl, founder and chairman of BioMEMS Diagnostics, shared how his business seeks to transform the diagnostics sector, in response to emailed questions.

94

94

MedCity News

FEBRUARY 16, 2023

A webinar sponsored by BD scheduled for March 7 will explore how diagnostics companies are working with healthcare organizations to guard against the perfect storm of Covid-19, RSV and influenza. Register today!

Healthcare 96

Healthcare Healthcare 96

Clarivate

NOVEMBER 7, 2023

If this resonates, an unbiased third-party evaluation, such as an IP Diagnostic, can help identify strategies to achieve key business priorities, gauge the efficacy of the team structure and technology in place and verify whether the processes are optimal. What is an IP Diagnostic?

Consulting 59

Consulting Prospecting Professional Services Management 59

PharmaTimes

SEPTEMBER 23, 2022

Link up will involve reporting on role of rapid diagnostics in taking on antimicrobial resistance

106

106

MedCity News

JULY 13, 2023

The Covid-19 pandemic changed the way we think of the role of diagnostics not only for clinicians but also consumers. The pandemic propelled innovation of in vitro diagnostics and the at-home test kits space for chronic conditions, sexual health, and more.

60

60

MedCity News

OCTOBER 2, 2022

The company — which is focused on improving transparency and access for diagnostic testing — will use the funds to enhance its platform’s price transparency tool and deploy it in physician offices so it can be used at the point of care. Virginia-based Careviso recently raised $17 million in Series B funds.

Physicians 88

Physicians 88

Medgadget

MAY 23, 2023

A recent study in Nature Medicine , entitled “ An automated histological classification system for precision diagnostics of kidney allografts ,” has showcased the efforts of a group of researchers who have developed an automated system that can diagnose kidney transplant rejection.

Physicians 83

Physicians Healthcare Provider Medical Medicine 83

Pharmaceutical Technology

FEBRUARY 29, 2024

After a challenging few years post-pandemic, industry professionals believe diagnostic testing is back on track

52

52

MedCity News

SEPTEMBER 9, 2022

Panelists at a session on diagnostics at MedtechVision 2022, a hybrid conference organized by MedtechWomen stressed that consumer and physician experience with a product is what is key in medtech innovation compared with simply adding bells and whistles.

Physicians 89

Physicians Patients 89

PharmaVoice

MAY 6, 2024

Tests frequently used in clinical trials will soon be regulated like medical devices — with some exceptions.

Pharma 94

Pharma Medical 94

PharmaTech

JUNE 1, 2023

Through the acquisition, Avacta gains Coris’ product portfolio consisting of diagnostic tests for respiratory, gastroenteric, and blood-borne pathogens as well as for the detection of antibiotic resistance markers.

59

59

MedCity News

AUGUST 15, 2022

Nanopath, a women’s health diagnostics startup, recently closed a $10 million in Series A funding round. The company will use the money to develop and commercialize its platform, which aims to diagnose women’s pelvic and gynecologic infections within minutes.

70

70

MedCity News

OCTOBER 31, 2022

Thermo Fisher Scientific’s acquisition of The Binding Site brings a company that specializes in diagnostic tests for blood cancers and immune system disorders. It’s Thermo Fisher’s biggest acquisition since its 2021 buyout of contract research organization PPD.

Specialization 83

Specialization Biopharma 83

Medgadget

OCTOBER 19, 2022

The researchers are in the process of conducting human trials of their system, in the hope that it will provide a viable diagnostic technology for Alzheimer’s disease. The assay is highly sensitive, allowing target protein measurements at femtogram levels.

Patients 107

Patients Medicine 107

Pharmaceutical Technology

SEPTEMBER 4, 2023

The company published a study showing lyso-Gb1 (glucosylsphingosine) as a diagnostic and predictive biomarker for the rare metabolic disease.

52

52

European Pharmaceutical Review

OCTOBER 6, 2022

Thomas Schinecker, CEO of Roche Diagnostics commented: “Previously, metastatic breast cancer patients with a lower level of HER2 expression were considered to be part of the HER2-negative population and had no HER2-targeted treatment options.

Food and Drug Administration 76

Food and Drug Administration Patients Safety Food 76

Pharmatutor

MARCH 16, 2022

ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP. Read more about ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP Log in or register to post comments About Author. Meenu Maurya. Email : meenudinesh15@gmail.com. Wed, 03/16/2022 - 15:06.

Medical 65

Medical 65

pharmaphorum

NOVEMBER 10, 2022

Preventive and diagnostic care is key to building more inclusive and resilient systems and procedures for the healthcare sector, but we have a long way to go before this vision becomes reality. Preventive vs. diagnostic care. Both prevention and diagnostics have a significant role to play in building the future of healthcare.

Healthcare 79

Healthcare Healthcare Medicine Management 79

Pharmaceutical Technology

APRIL 12, 2023

Foundation Medicine has announced it will supply a tissue-based test as a companion diagnostic for Bristol Myers Squibb’s (BMS) recently acquired ROS1/TRK inhibitor repotrectinib. FoundationOne CDx is a sequencing-based in vitro diagnostic device that can identify alterations in 324 genes from tumour samples.

Medicine 52

Medicine Patients Leads 52

Medgadget

JULY 12, 2022

Despite the human cost of the disease, current diagnostic approaches are not fit for purpose, particularly in areas with underdeveloped medical systems. Typhoid kills tens of thousands of people every year, and is primarily observed in remote and poorer regions of the world, where it typically spreads through contaminated food and water.

Food 84

Food Medical Medicine 84

Legacy MEDSearch

OCTOBER 17, 2023

FloBio , a medical diagnostics company, announced today that the U.S. Food and Drug Administration has granted Breakthrough Device Designation for its rapid bleeding risk diagnostic test. Clinicians do not have effective bedside diagnostics to assess DOAC status. DOACs can elevate bleeding risk and complicate emergency care.

Food and Drug Administration 52

Food and Drug Administration Recruitment FDA Management 52

Legacy MEDSearch

JANUARY 18, 2023

Cytovale ® , a medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced today that its IntelliSep ® test has received U.S. IntelliSep will be available in the United States in the coming weeks. About IntelliSep ®. Press Release by: Cytovale.

Food and Drug Administration 98

Food and Drug Administration FDA Recruitment Physicians 98

PharmaTech

JUNE 15, 2023

The integration of the binders into a routine lateral flow test will support the clinical and commercial development of rapid diagnostics for Alzheimer’s disease through nasal sampling.

52

52

Pharmacy Times

AUGUST 29, 2023

Pharmacists can actively engage in the implementation of the Comprehensive Diagnostics and Examinations in Acute Coronary Syndromes pathway within the hospital or health care system.

49

49

Pharmaceutical Technology

SEPTEMBER 1, 2022

Analysts at GlobalData predict that the market for point-of-care (POC) diagnostic devices will reach $297.6bn by 2023, a growth of almost $1bn from 2015. As such, POC diagnostics are well positioned to challenge traditional centralised laboratory methods. Manufacturing challenges.

Manufacturing 52

Manufacturing Pharmaceutical Consulting Marketing 52

PharmaTech

JANUARY 26, 2023

Agilent will work with Quest Diagnostics to distribute the ctDx FIRST test.

Distribution 40

Distribution 40

Pharmaceutical Technology

DECEMBER 12, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Guangzhou Kingmed Diagnostics Group here.

52

52

Legacy MEDSearch

APRIL 18, 2023

Caristo Diagnostics Limited , a global leader in cardiac and vascular disease diagnostics and risk prediction, today announced it has secured a further £13 million (US$16.3 Caristo aims to change this statistic through the delivery of its state-of-the-art coronary disease diagnostic technology. million lives each year 1.

Recruitment 52

Recruitment Networking Marketing Healthcare 52

Clarify Health

FEBRUARY 2, 2022

Pfizer partnered with Clarify on an observational study on diagnostic testing patterns in transthyretin amyloid cardiomyopathy (ATTR-CM) patients. However, the frequency of diagnostic use of tissue biopsy and myocardial scintigraphy in clinical practice is not yet well established.

Patients 52

Patients Insurance Physicians Leads 52